Cargando…

Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial

OBJECTIVE: To evaluate if daily oral 75 µg of Desogestrel (DSG) for 3 months prior to the insertion of etonogestrel-releasing contraceptive implant (ENG-IMPLANT) might help reduce its premature discontinuation. RESULTS: A total of 66 women were randomized in the ENG-IMPLANT group (26) and in the DSG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lombardi Fäh, Valeria, Catarino, Rosa, Castillo, Sarah, Badda, Maria, Gezer-Dickschat, Sibel, Thieringer, Friederike, Tschudin, Sibil, Viviano, Manuela, Yaron, Michal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010063/ https://www.ncbi.nlm.nih.gov/pubmed/36915205 http://dx.doi.org/10.1186/s13104-023-06304-3

Ejemplares similares

Three-year observational study of immediate post-abortion insertion versus menstrual insertion of etonogestrel contraceptive implant
por: Zheng, Wanren, et al.
Publicado: (2021)

Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive
por: Hohmann, Heather
Publicado: (2009)

Pulmonary embolism in a healthy woman using the oral contraceptives containing desogestrel
por: Park, Min-Jeong, et al.
Publicado: (2017)

Esters of levonorgestrel and etonogestrel intended as single, subcutaneous-injection, long-lasting contraceptives
por: Meece, Frederick A., et al.
Publicado: (2018)

Desogestrel: Arterial thrombosis: case report
Publicado: (2021)

The Uncharted Link Between Desogestrel and Hypercalcemia
por: Utpat, Nishka, et al.
Publicado: (2023)

A Comparative Efficacy of Low-Dose Combined Oral Contraceptives Containing Desogestrel and Drospirenone in Premenstrual Symptoms
por: Wichianpitaya, Jirath, et al.
Publicado: (2013)

Etonogestrel contraceptive implant failure in a woman taking rifampin: a case report
por: Tufa, Tesfaye H., et al.
Publicado: (2022)

Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria
por: Moeti, Dikonketjo M.P., et al.
Publicado: (2022)

Retrospective Analysis of the Effectiveness and Reversibility of Long-Acting Contraception Etonogestrel (Implanon(®)) in Common Marmosets (Callithrix jacchus)
por: Roubos, Sandra, et al.
Publicado: (2021)

A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants
por: Monteiro-Dantas, Cecilia, et al.
Publicado: (2007)

Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant
por: Ali, Moazzam, et al.
Publicado: (2016)

A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant
por: Moray, Kusum V., et al.
Publicado: (2021)

Etonogestrel Implant—To Leave or Stay: A Case Series
por: Thew, Margaret
Publicado: (2017)

Diagnosis of Intrauterine Pregnancy Despite the Presence of Etonogestrel Implant
por: Sawyers, Ryan J, et al.
Publicado: (2022)

A case report on variegate porphyria after etonogestrel placement
por: Strome, Arianna, et al.
Publicado: (2022)

Continuation Rates of the Etonogestrel Implant and Factors Associated With Early Discontinuation
por: Hines, Genesis, et al.
Publicado: (2023)

Hormonal, apoptotic, proliferative and inflammatory markers’ expression in Desogestrel-treated women with ovarian endometriosis
por: Matasariu, Daniela-Roxana, et al.
Publicado: (2022)

Reversible median nerve neuropathy and local muscle irritation resulting from blind removal attempts of etonogestrel contraceptive implant: a case report
por: Fungtammasan, Siraphat, et al.
Publicado: (2023)

Toxic epidermal necrolysis caused by etonogestrel implantation: A rare presentation
por: Amin, Minorvi, et al.
Publicado: (2022)

Infective Endocarditis in Hypertrophic Obstructive Cardiomyopathy After Etonogestrel Implant Removal
por: Dlewati, Mohammad M, et al.
Publicado: (2022)

Considerations in Adolescent Use of the Etonogestrel Subdermal Implant: A Cohort Study
por: Fei, Y. Frances, et al.
Publicado: (2021)

The interrelation between premenstrual syndrome and major depression: Results from a population-based sample
por: Forrester-Knauss, Christine, et al.
Publicado: (2011)

Portal Venous Thrombosis Associated with Use of Etonogestrel/ethinyl Estradiol Vaginal Ring
por: Bailey, Katelynn E., et al.
Publicado: (2020)

Reproductive health care for asylum-seeking women - a challenge for health professionals
por: Kurth, Elisabeth, et al.
Publicado: (2010)

Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling
por: Ali, Moazzam, et al.
Publicado: (2017)

Decreased efficacy of an etonogestrel implant in a woman on antiepileptic medications: a case report
por: Lange, Jill, et al.
Publicado: (2014)

Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients
por: Wu, Jianbo, et al.
Publicado: (2018)

Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and blood
por: Haddad, Lisa B., et al.
Publicado: (2020)

Comparative evaluation of low-level light therapy and ethinyl estradiol and desogestrel combined oral contraceptive for clinical efficacy and regulation of serum biochemical parameters in primary dysmenorrhoea: a prospective randomised multicentre trial
por: Zhu, Shiyang, et al.
Publicado: (2022)

Cerebral Sinus Venous Thrombosis in a Patient Using Etonogestrel/Ethinyl Estradiol Vaginal Ring
por: Selim, Mohammad, et al.
Publicado: (2018)

Impact of a brochure and empathetic physician communication on patients’ perception of breast biopsies
por: Machacek, Martina, et al.
Publicado: (2023)

Desogestrel and panic attacks – a new suspected adverse drug reaction reported by patients and health care professionals on spontaneous reports
por: Watson, Sarah, et al.
Publicado: (2018)

The effectiveness of desogestrel for endometrial protection in women with abnormal uterine bleeding-ovulatory dysfunction: a non-inferiority randomized controlled trial
por: Soontrapa, Nisarath, et al.
Publicado: (2022)

Swiss gynecologists’ opinions and perceptions concerning the use of intrauterine devices by nulliparous and multiparous women: an online survey study
por: Zimmermann, Yaël, et al.
Publicado: (2019)

Subcutaneous implant with etonogestrel (Implanon®) for catamenial exacerbations in a patient with cystic fibrosis: a case report
por: Lamas, Adelaida, et al.
Publicado: (2014)

Etonogestrel Administration Reduces the Expression of PHOX2B and Its Target Genes in the Solitary Tract Nucleus
por: Cardani, Silvia, et al.
Publicado: (2022)

Serotonin and the ventilatory effects of etonogestrel, a gonane progestin, in a murine model of congenital central hypoventilation syndrome
por: Casciato, Alexis, et al.
Publicado: (2023)

Post placental insertion of intrauterine contraceptive device
por: Suri, Vanita
Publicado: (2012)

Management of pain associated with the insertion of intrauterine contraceptives
por: Gemzell-Danielsson, K., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_13vn2gq21hrnc42vislfsa06oi